Vitamin D Deficiency and Hashimoto's Thyroiditis in Children and Adolescents: a Critical Vitamin D Level for This Association?

被引：31

作者：

Evliyaoglu, Olcay ^{[1
]}

Acar, Manolya ^{[1
]}

Ozcabi, Bahar ^{[1
]}

Erginoz, Ethem ^{[2
]}

Bucak, Feride ^{[1
]}

Ercan, Oya ^{[1
]}

Kucur, Mine ^{[3
]}

机构：

[1] Istanbul Univ, Cerrahpasa Fac Med, Dept Pediat Endocrinol, Istanbul, Turkey

[2] Istanbul Univ, Cerrahpasa Fac Med, Dept Publ Hlth, Istanbul, Turkey

[3] Istanbul Univ, Cerrahpasa Fac Med, Dept Biochem, Istanbul, Turkey

来源：

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY | 2015年 / 7卷 / 02期

关键词：

Hashimoto thyroiditis; vitamin D; deficiency; children; adolescents; 1,25-DIHYDROXYVITAMIN D-3; D-RECEPTOR; AUTOIMMUNE-DISEASE; TARGET; RISK; ENCEPHALOMYELITIS; ANALOG; CELLS; GENE; 25-HYDROXYVITAMIN-D;

D O I：

10.4274/jcrpe.2011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: Vitamin D has been suggested to be active as an immunomodulator in autoimmune diseases such as Hashimoto's thyroiditis (HT). The goal of the present study was to investigate the vitamin D status in HT patients. Methods: This prevalence case-control study was conducted on 90 patients with HT (of ages 12.32 +/- 2.87 years) and 79 age-matched healthy controls (11.85 +/- 2.28 years). Serum 25-hydroxyvitamin D3 [25(OH)D3] levels were measured in all 169 subjects. Results: The prevalence of vitamin D deficiency in HT patients (64 of 90; 71.1%) was significantly higher than that in the control group (41 of 79; 51.9%) (p=0.025). Mean serum 25(OH)D3 level in the HT group was significantly lower compared to the control group (16.67 +/- 11.65 vs. 20.99 +/- 9.86 ng/mL, p=0.001). HT was observed 2.28 times more frequently in individuals with 25(OH) D3 levels <20 ng/mL (OR: 2.28, CI: 1.21-4.3). Conclusion: Vitamin D deficiency is associated with HT in children and adolescents. Levels lower than 20 ng/mL seem to be critical. The mechanism for this association is not clear.

引用

页码：128 / 133

页数：6

共 45 条

[21] Larsson P, 1998, CLIN EXP IMMUNOL, V114, P277
[22] 1,25-DIHYDROXYVITAMIN-D3 PREVENTS THE INVIVO INDUCTION OF MURINE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
LEMIRE, JM
ARCHER, DC
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) : 1103 - 1107
[23] Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
Liu, PT
Stenger, S
Li, HY
Wenzel, L
Tan, BH
Krutzik, SR
Ochoa, MT
Schauber, J
Wu, K
Meinken, C
Kamen, DL
Wagner, M
Bals, R
Steinmeyer, A
Zügel, U
Gallo, RL
Eisenberg, D
Hewison, M
Hollis, BW
Adams, JS
Bloom, BR
Modlin, RL
[J]. SCIENCE, 2006, 311 (5768) : 1770 - 1773
[24] Vitamin D discovery outpaces FDA decision making
Marshall, Trevor G.
[J]. BIOESSAYS, 2008, 30 (02) : 173 - 182
[25] The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents
Mathieu, C
Adorini, L
[J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) : 174 - 179
[26] PREVENTION OF TYPE-I DIABETES IN NOD MICE BY NONHYPERCALCEMIC DOSES OF A NEW STRUCTURAL ANALOG OF 1,25-DIHYDROXYVITAMIN D-3, KH1060
MATHIEU, C
WAER, M
CASTEELS, K
LAUREYS, J
BOUILLON, R
[J]. ENDOCRINOLOGY, 1995, 136 (03) : 866 - 872
[27] Mattner F, 2000, EUR J IMMUNOL, V30, P498, DOI 10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO
[28] 2-Q
[29] 25-hydroxyvitamin D levels and the risk of mortality in the general population
Melamed, Michal L.
Michos, Erin D.
Post, Wendy
Astor, Brad
[J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) : 1629 - 1637
[30] Vitamin D deficiency in children and its management: Review of current knowledge and recommendations
Misra, Madhusmita
Pacaud, Daniele
Petryk, Anna
Collett-Solberg, Paulo Ferrez
Kappy, Michael
[J]. PEDIATRICS, 2008, 122 (02) : 398 - 417

← 1 2 3 4 5 →